Analysis of T and NK cells immune response in Ipilimumab treated Melanoma patients

被引：0
|
作者：
Rossana Tallerico
Costanza M Cristiani
Mariaelena Capone
Gabriele Madonna
Domenico Mallardo
Ester Simeone
Andrea Dominijanni
Antonio M Grimaldi
Francesco Colucci
Paolo A Ascierto
Ennio Carbone
机构：
[1] University "Magna Graecia" of Catanzaro,Tumorimmunology and Immunopathology Laboratory, Department of Experimental and Clinic Medicine
[2] Istituto Nazionale Tumori Fondazione "G. Pascale",Melanoma. CancerImmunotherapy and Innovative Therapy Unit
[3] Immunohaematological Transfusion Medicine Centre “Pugliese-Ciaccio” Hospital of Catanzaro,Department of Obstetrics and Gynaecology
[4] University of Cambridge Clinical School,Department of Microbiology Cell and Tumorbiology (MTC)
[5] Karolinska Institutet,undefined
来源：
Journal of Translational Medicine | / 13卷 / Suppl 1期
关键词：
Melanoma; Metastatic Melanoma; Melanoma Patient; Ipilimumab; Cell Immune Response;
D O I：
10.1186/1479-5876-13-S1-O8
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Predictive immune markers in advanced melanoma patients treated with ipilimumab
    Umansky, Viktor
    Utikal, Jochen
    Gebhardt, Christoffer
    ONCOIMMUNOLOGY, 2016, 5 (06):
  • [2] Phenotypic and functional testing of circulating regulatory T cells in advanced melanoma patients treated with neoadjuvant ipilimumab
    Retseck, Janet
    VanderWeele, Robert
    Lin, Hui-Min
    Lin, Yan
    Butterfield, Lisa H.
    Tarhini, Ahmad A.
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2016, 4
  • [3] MISIPI study: Melanoma ImmunoScore evaluation in patients treated with IPIlimumab
    Carlo Bifulco
    Marilena Capone
    Zip Feng
    Gabriele Madonna
    Ester Simeone
    Marcello Curvietto
    Nicola Mozzillo
    Gennaro Ciliberto
    Gerardo Botti
    Bernard A Fox
    Paolo A Ascierto
    Journal of Translational Medicine, 12 (Suppl 1)
  • [4] The proportion of circulating CD45RO+CD8+ memory T cells is correlated with clinical response in melanoma patients treated with ipilimumab
    Tietze, Julia K.
    Angelova, Daniela
    Heppt, Markus V.
    Reinholz, Markus
    Murphy, William J.
    Spannagl, Michael
    Ruzicka, Thomas
    Berking, Carola
    EUROPEAN JOURNAL OF CANCER, 2017, 75 : 268 - 279
  • [5] Ipilimumab reshapes T cell memory subsets in melanoma patients with clinical response
    Felix, Joana
    Lambert, Jerome
    Roelens, Marie
    Maubec, Eve
    Guermouche, Helene
    Pages, Cecile
    Sidina, Irina
    Cordeiro, Debora J.
    Maki, Guitta
    Chasset, Francois
    Porcher, Raphael
    Bagot, Martine
    Caignard, Anne
    Toubert, Antoine
    Lebbe, Celeste
    Moins-Teisserenc, Helene
    ONCOIMMUNOLOGY, 2016, 5 (07):
  • [6] Long-lasting complete response of metastatic melanoma to ipilimumab with analysis of the resident immune cells
    Tsaknakis, Birgit
    Schaefer, Inga-Marie
    Schwoerer, Harald
    Sahlmann, Carsten-Oliver
    Thoms, Kai-Martin
    Blaschke, Martina
    Ramadori, Giuliano
    Cameron, Silke
    MEDICAL ONCOLOGY, 2014, 31 (01)
  • [7] Long-lasting complete response of metastatic melanoma to ipilimumab with analysis of the resident immune cells
    Birgit Tsaknakis
    Inga-Marie Schaefer
    Harald Schwörer
    Carsten-Oliver Sahlmann
    Kai-Martin Thoms
    Martina Blaschke
    Giuliano Ramadori
    Silke Cameron
    Medical Oncology, 2014, 31
  • [8] Improved survival and complete response rates in patients with advanced melanoma treated with concurrent ipilimumab and radiotherapy versus ipilimumab alone
    Koller, Kristian M.
    Mackley, Heath B.
    Liu, Jason
    Wagner, Henry
    Talamo, Giampaolo
    Schell, Todd D.
    Pameijer, Colette
    Neves, Rogerio I.
    Anderson, Bryan
    Kokolus, Kathleen M.
    Mallon, Carol A.
    Drabick, Joseph J.
    CANCER BIOLOGY & THERAPY, 2017, 18 (01) : 36 - 42
  • [9] Retrospective study of advanced melanoma patients treated with ipilimumab after nivolumab: Analysis of 60 Japanese patients
    Fujisawa, Yasuhiro
    Yoshino, Koji
    Otsuka, Atsushi
    Funakoshi, Takeru
    Uchi, Hiroshi
    Fujimura, Taku
    Matsushita, Shigeto
    Hata, Hiroo
    Okuhira, Hisako
    Tanaka, Ryota
    Nagai, Kojiro
    Ishida, Yoshihiro
    Nakamura, Yoshio
    Furudate, Sadanori
    Yamamura, Kentaro
    Imafuku, Keisuke
    Yamamoto, Yuki
    JOURNAL OF DERMATOLOGICAL SCIENCE, 2018, 89 (01) : 60 - 66
  • [10] Biomarkers Associated with Clinical Outcome of Advanced Melanoma Patients Treated with Ipilimumab
    Balatoni, Timea
    Ladanyi, Andrea
    Frohlich, Georgina
    Czirbesz, Kata
    Kovacs, Peter
    Panczel, Gitta
    Bence, Eszter
    Plotar, Vanda
    Liszkay, Gabriella
    PATHOLOGY & ONCOLOGY RESEARCH, 2020, 26 (01) : 317 - 325
12345